Share Twitter LinkedIn Facebook Email Alok Khorana, MD of the Cleveland Clinic discusses the prevalence and consequences of VTE and increased chance of fatality and admissions to the hospital at the 2017 American Society of Hematology. Advertisement
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read
Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD Acute Lymphoblastic Leukemia 4 Mins Read